| 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交全额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-12-17 | 300582 | 英飞特 | 12.81 | 16.00 | 204.96 | 机构专用 | 国信证券股份有限 | | | | | | | | | 公司杭州分公司 | | 2025-12-17 | 300582 | 英飞特 | 12.81 | 15.61 | 200.00 | 国投证券股份有限 | 国信证券股份有限 | | | | | | | | 公司连云港郁州北 | 公司杭州分公司 | | | | | | | | 路证券营业部 | | | 2025-12-17 | 300582 | 英飞特 | 12.81 | 15.62 | 200.09 | 华泰证券股份有限 | 国信证券股份有限 | | | | | | | | 公司广东分公司 | 公司杭州分公司 | 12月17日，英飞特大宗交易成交47.23 ...

证券日报网讯 12月5日，英飞特在互动平台回答投资者提问时表示，公司严格按照法律法规的要求，及 时履行信息披露义务。关于减持进展内容请关注公司公告。 （文章来源：证券日报） ...

12月1日，英飞特（300582）宣布与Synapse Wireless建立战略合作伙伴关系，共同致力于为全球市场提 供稳定、高效、高度兼容的照明系统解决方案。 作为行业领先的端到端无线控制系统服务商，Synapse Wireless深耕能耗优化赛道，核心聚焦以创新控 制系统技术降低终端能耗；英飞特则在LED驱动电源领域积淀了深厚的技术壁垒与市场口碑，双方形成 硬件核心与软件赋能的优势互补格局。此次强强联合，将聚焦体育与户外场景，共同打造专业协同的一 体化系统解决方案，依托各自在细分领域的长期技术积累与实践经验，确保方案配置成熟度与系统运行 稳定性，为客户提供高可靠性的产品与服务支持。 随着英飞特与Synapse Wireless联合产品匹配清单的落地及场景化解决方案的持续迭代，英飞特有望进 一步巩固在传统照明市场的主导地位，更有望在更多细分赛道增量领域打开成长空间，持续强化差异化 竞争优势。 体育与户外照明、植物照明等新兴赛道是英飞特前瞻布局的LED核心应用场景。公司凭借大功率驱动电 源技术与城市智慧照明解决方案的核心优势，已稳固占据道路及区域照明市场主导地位；通过整合欧司 朗DS-E业务在中小功率领域的技 ...

杭州市上城区钱江新城城星路 69 号中天国开大厦 10/12 层 310020 10&12/F, Zhongtian Guokai Building, 69 Chengxing Road, Qianjiang CBD, Shangcheng District, Hangzhou 310020, China 电话 Tel: +86 571 8829 8760 电邮 Email: hangzhou@tongshang.com 网址 Web: www.tongshang.com 北京通商（杭州）律师事务所 关于英飞特电子（杭州）股份有限公司 致：英飞特电子（杭州）股份有限公司 北京通商（杭州）律师事务所（以下简称"本所"）接受英飞特电子（杭州） 股份有限公司（以下简称"公司"）委托，指派本所律师对公司召开 2025 年第二 次临时股东会（以下简称"本次股东会"）的合法性进行见证并出具本法律意见书。 为出具本法律意见书，本所律师审查了公司提供的与本次股东会相关的文件 和资料，同时听取了公司人员就有关事实的陈述和说明。本所已得到公司的如下 保证，保证其所提供的文件和资料是真实、准确、完整的，并无隐瞒、虚假和重 大遗漏之 ...

证券代码：300582 证券简称：英飞特 公告编号：2025-069 英飞特电子（杭州）股份有限公司 3、本次股东会采用现场投票和网络投票相结合的表决方式进行； 4、本次股东会对中小投资者进行单独计票。中小投资者是指除单独或合计 持有上市公司5%以上股份的股东以及上市公司的董事、高级管理人员以外的其 他股东。 一、会议召开和出席情况 1、英飞特电子（杭州）股份有限公司（以下简称"公司"）2025年第二次临 时股东会会议通知于2025年11月13日以公告形式发出。 2、会议召开方式：本次会议以现场投票与网络投票相结合的方式召开。 3、会议召开时间： 2025 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 特别提示 1、本次股东会没有出现否决议案的情形； 2、本次股东会没有涉及变更前次股东会决议的情形； 1）现场会议召开时间：2025年11月28日（周五）下午 14:40 2）网络投票时间：2025年11月28日。其中，通过深圳证券交易所（以下简 称"深交所"）交易系统进行网络投票的时间为深圳证券交易所交易时间，即2025 年11月 ...

Core Viewpoint - The company, Infit, primarily engages in the research, production, sales, and technical services of LED lighting supporting products, including LED drivers, sensors, control systems, and LED modules [1] Group 1: Company Overview - Infit focuses on LED lighting products and solutions, indicating a strong presence in the LED market [1] - The company also offers energy storage solutions, specifically targeting commercial and residential sectors, although the current scale of this segment is relatively small [1]

Core Viewpoint - The company, Infinet (300582.SZ), focuses on the research, production, sales, and technical services of LED lighting products, including LED drivers, sensors, control systems, and LED modules [1] Group 1: Company Overview - The main business activities of the company include the development and production of LED lighting supporting products [1] - The company also offers energy storage solutions, primarily targeting commercial and residential sectors, although its current scale in this area is relatively small [1]

Group 1 - China Pacific Insurance's subsidiary, China Pacific Life, reported a cumulative premium income of 241.32 billion yuan for the first ten months, a year-on-year increase of 9.9% [1] - China Pacific Property Insurance, another subsidiary, achieved a cumulative premium income of 173.57 billion yuan, with a year-on-year growth of 0.4% [1] - Nocera Biopharma reported a net loss of 64.41 million yuan for the first three quarters, despite a revenue increase of 59.85% to 1.115 billion yuan [1] Group 2 - Founder Securities received approval from the China Securities Regulatory Commission to issue short-term corporate bonds not exceeding 5 billion yuan [1] - Haicheng Bonda's director plans to reduce his stake by up to 0.97%, equating to 198,400 shares [1] - Yuyuan Group intends to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 8.60 yuan per share [1] Group 3 - Huaren Shuanghe's subsidiary passed the GMP compliance inspection for a specific diabetes medication [4] - Lichong Group received project notifications from three international automotive manufacturers, with expected sales amounting to approximately 1.135 billion yuan [6] - Deyang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [7] Group 4 - Longxin General announced the transfer of its entire stake in a subsidiary for 105.6 million yuan, and also plans to divest another stake for 1 yuan due to poor performance [16] - Kangda New Materials decided to terminate the acquisition of a semiconductor company due to unsatisfactory due diligence progress [17] - Lu'an Environmental reported a 3.28% year-on-year increase in coal sales for October, totaling 3.78 million tons [18] Group 5 - Shanghai Port Group plans to invest 2 billion yuan to establish a new holding company with several state-owned enterprises [20] - Borui Pharmaceutical's new drug for obesity treatment has received clinical trial approval [23] - Silver Dragon Co. has completed the registration of a new energy industry fund focusing on high-growth potential projects [24] Group 6 - Hengrui Medicine received approval for a clinical trial of a prostate cancer drug [11] - Baiji Shenzhou reported a net profit of 1.139 billion yuan for the first three quarters, marking a turnaround from losses [36] - Huasheng Pharmaceutical's special medical food product has received registration certification [60]

Group 1 - The company Infit (300582.SZ) announced that its wholly-owned subsidiary, Hangzhou Infit Equity Investment Co., Ltd., will invest in Qinghai Spring Warm Flower Biotechnology Co., Ltd. and its existing shareholders through a capital increase and share transfer agreement [1] - The investment includes a cash contribution of 13.44 million yuan to increase the registered capital of Spring Warm Flower by 1.344 million yuan, with the remaining amount recorded as capital surplus [1] - After the transaction, the company will directly hold 2.62% of the equity in the target company and indirectly hold 3.04% through Blincao Biotechnology [1] Group 2 - This transaction allows the company to deepen its application scenarios in plant/biological lighting, accurately understand customer needs, and iteratively improve LED driver power supplies, sensors, and control systems [2] - The strategic shift from a "single hardware supplier" to a "system solution provider" will enhance customer loyalty and technical barriers, maintaining the company's competitive advantage in the plant (biological) lighting segment [2]

Group 1 - The company announced that its wholly-owned subsidiary, Hangzhou Infit Investment Co., Ltd., will invest 13.44 million yuan in Qinghai Spring Warm Flower Biotechnology Co., Ltd. and acquire shares from existing shareholders [1] - After the transaction, the company will directly hold 2.62% of the target company's equity and indirectly hold 3.04% through Blincao Biotechnology [2] - This transaction aims to enhance the application scenarios of plant/biological lighting, allowing the company to better understand customer needs and transition from a "single hardware supplier" to a "system solution provider" [2]